Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation

1 Oct 2024

Abstract excerpt

Chronic hepatitis B (CHB) is a chronic inflammatory disease of the liver caused by infection with the hepatitis B virus (HBV), which in later stages can lead to the development of end-stage liver diseases such as cirrhosis and hepatocellular carcinoma in severe cases, jeopardizing long-term quality of life, with a poor prognosis, and placing a serious financial burden on many families around the world. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug-Induced Hepatotoxicity and Protection
Share to Hepatitis B Virus Studies
Share to Hepatitis C virus research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39640799
DOI: 10.1016/j.heliyon.2024.e39176

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulationPMID 39640799Read ↗

The Mechanisms of Yinchensini Decoction in Treating Hepatitis B were Explored by Network Pharmacology and Existing LiteraturesSemantic proximity Read ↗

The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathwaysSemantic proximity Read ↗

Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways.Semantic proximity Read ↗

Regulatory effect of traditional Chinese medicines on signaling pathways of process from chronic atrophic gastritis to gastric cancerSemantic proximity Read ↗

TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and CarcinogenesisSemantic proximity Read ↗

TGF-β signaling pathway as a pharmacological target in liver diseasesSemantic proximity Read ↗

The Therapeutic Potential of Chi Shao and Fu Zi in Acute-on-Chronic Liver Failure: Insights from Network Pharmacology and Animal StudiesSemantic proximity Read ↗

Novel therapies and potential therapeutic targets in the management of chronic hepatitis B.Semantic proximity Read ↗

Anti-HBV Therapy in Hepatocellular Carcinoma May Affect the Symptoms of SARS-CoV-2 InfectionSemantic proximity Read ↗

Role of miRNA-4804-3p in liver injury of chronic hepatitis B through inhibit chemerin/chemokine-like receptor 1 mediated NF-κB signal pathwaySemantic proximity Read ↗

MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosisSemantic proximity Read ↗

Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.